Decreased Levels of miR-126 and miR-132 in Plasma and Vitreous Humor of Non-Proliferative Diabetic Retinopathy Among Subjects with Type-2 Diabetes Mellitus
Subhasish Pramanik,Chinmay Saha,Subhankar Chowdhury,Chiranjit Bose,Nitai P Bhattacharyya,Lakshmi Kanta Mondal
DOI: https://doi.org/10.2147/DMSO.S346097
2022-02-04
Abstract:Subhasish Pramanik, 1, &ast Chinmay Saha, 1, 2, &ast Subhankar Chowdhury, 1 Chiranjit Bose, 1 Nitai P Bhattacharyya, 1 Lakshmi Kanta Mondal 3 1 Department of Endocrinology & Metabolism, Institute of Post Graduate Medical Education & Research and SSKM Hospital, Kolkata, 700020, West Bengal, India; 2 Genome Science, School of Interdisciplinary Studies, University of Kalyani, Nadia, 741235, West Bengal, India; 3 Department of Ophthalmology, Regional Institute of Ophthalmology, Medical College Campus, Kolkata, 700 073, West Bengal, India &astThese authors contributed equally to this work Correspondence: Subhankar Chowdhury Department of Endocrinology & Metabolism, Institute of Post Graduate Medical Education & Research and SSKM Hospital, Kolkata, 700020, West Bengal, India , Email Lakshmi Kanta Mondal Department of Ophthalmology, Regional Institute of Ophthalmology, Medical College Campus, 88, College Street, Kolkata, 700 073, West Bengal, India , Email Purpose: Diabetic retinopathy (DR), the leading cause of blindness among working adults, is an urgent public health problem as diabetes mellitus (DM) is increasing at an alarming rate. Hyperglycemia-induced endothelial dysfunction is the principal contributing factor leading to the development of microangiopathy. Altered levels of microRNA (miR), the negative regulator of protein-coding genes, have been observed and considered to be markers for DR. Present study aimed to find out whether miR levels in plasma could be effective biomarkers to differentiate between type 2 diabetes mellitus (T2DM) with non-proliferative retinopathy (NPDR) from T2DM with no-DR (DNR). Methods: We recruited 50 T2DM subjects comprising 31 NPDR and 19 DNR individuals. Surrogate markers of systemic oxidative stress and vascular endothelial growth factor (VEGF) were measured in plasma. Levels of miR-126 and miR-132 were determined in plasma and vitreous fluid using real-time PCR. Results: We observed that levels of miR-126 and miR-132 were decreased in NPDR subjects in comparison to DNR. Plasma levels of miRs were inversely correlated with secreted levels of VEGF and oxidative stress marker. The levels of these miRs showed discriminating ability between NPDR and DNR. Conclusion: Circulating miRs 126 and 132 in plasma or vitreous may serve as biomarkers for early diabetic retinopathy risk prediction, provided validated in a larger cohort and other forms of retinal vasculopathy or retinopathy in the future. Keywords: diabetic retinopathy, microRNA-126, microRNA-132, oxidative stress, malondialdehyde, vascular endothelial growth factor Among various microvascular complications resulting from long-standing Type 2 diabetes mellitus (T2DM), diabetic retinopathy (DR) is a major complication leading to visual loss in the working-age population. About one-third of the T2DM patient develops a severe form of DR namely proliferative diabetic retinopathy (PDR) through an early stage of the disease known as nonproliferative diabetic retinopathy (NPDR). Increased vascular permeability and capillary occlusion in the retinal vasculature in NPDR produce microaneurysms, hemorrhages, and exudates. Ultimately, neovascularization in the retina owing to persistent ischemia in the capillary beds characterizes PDR and invites severe vision impairment. 1–3 Poor glycemic control is considered to be a principal contributing factor to the development of DR. However, in some cases of DR, intensive control of blood sugar did not show a preventive effect against the initiation of DR. 4–6 It is assumed that on the background of genetic predisposition, hyperglycemia-induced biochemical derangements ie production of free radicals, advanced glycosylation end products, and lipid peroxidation converge to the pathways of inflammation, and tissue hypoxia, which ultimately lead to increased secretion of vascular endothelial growth factor (VEGF). 7–9 VEGF mediated through activation of hypoxia-inducible factor 1-alpha (HIF1-α), plays crucial roles in the development of DR. 8–12 VEGF enhances vascular permeability by phosphorylation of tight junction proteins like zonula occludens-1 (ZO-1) and occludin. 13 VEGF also promotes the proliferation of endothelial cells by activation of the mitogen-activated protein (MAP). 14 However, apoptotic cell death of endothelial cells and thickening of basement membrane are observed during the early stage of development of DR. 15–17 It is assumed that in response to hyperglycemia-mediated anomalous biochemical pathways in diabetes, diverse cellular alterations like in -Abstract Truncated-
endocrinology & metabolism